(Q53573413)
Statements
Outcomes and cost benefits associated with the introduction of inhaled corticosteroid therapy in a medicaid population of asthmatic patients. (English)
Balkrishnan R
Norwood GJ
Anderson A
1 May 1998
20
3
567-580